Detalhe da pesquisa
1.
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 Mutation-Positive, Early-Stage Triple-Negative Breast Cancer: Results of a Phase II Study.
Oncologist
; 28(10): 845-855, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318349
2.
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes.
Breast Cancer Res Treat
; 202(1): 191-201, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589839
3.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.
J Natl Compr Canc Netw
; 21(6): 594-608, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308117
4.
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(6): 691-722, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714673
5.
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
Lancet
; 396(10257): 1090-1100, 2020 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966830
6.
NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
J Natl Compr Canc Netw
; 19(5): 484-493, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794122
7.
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer.
Circulation
; 139(21): 2451-2465, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30866650
8.
Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(4): 452-478, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259783
9.
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
Proc Natl Acad Sci U S A
; 114(52): 13792-13797, 2017 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229854
10.
NCCN Guidelines Updates: Breast Cancer.
J Natl Compr Canc Netw
; 17(5.5): 552-555, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117035
11.
NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
J Natl Compr Canc Netw
; 17(2): 118-126, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30787125
12.
Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.
Breast Cancer Res Treat
; 168(3): 625-630, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29275435
13.
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 16(3): 310-320, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523670
14.
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale.
Future Oncol
; 13(4): 307-320, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739325
15.
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
Ann Surg Oncol
; 23(10): 3310-6, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401442
16.
BROCADE3: a challenge to the treatment paradigm in BRCA breast cancer?
Lancet Oncol
; 21(10): 1254-1255, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861274
17.
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Breast Cancer Res
; 16(2): R36, 2014 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708766
18.
(18)F-FPPRGD2 PET/CT: pilot phase evaluation of breast cancer patients.
Radiology
; 273(2): 549-59, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25033190
19.
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
BMC Cancer
; 14: 456, 2014 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947048
20.
Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California Breast Cancer Family Registry.
JNCI Cancer Spectr
; 8(2)2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547391